Non-invasive detection of fetal RHD status is vital to enable targeted

prophylaxis to mothers at risk, eliminating unnecessary administration of

human blood-based products while reducing immunization.

Therefore, Devyser will be hosting their next webinar on choosing and implementing the best screening method for non-invasive fetal-RHD testing!

The Karolinska University Hospital has pioneered large-scale non-invasive fetal

RHD screening in pregnant RhD negative women in Sweden.

Professor Agneta Wikman will share her experiences from the

last decade in a recent publication and in this webinar.

The following shall be covered during the discussion :

Single exon feature

Sample handling

Clinical outcome

Webinar details

Wednesday, September 21st 2022

4-4:30 pm JST (3-3.30 pm SGT)

10-10:30 am CEST (4-4.30 pm SGT)

10-10:30 am PST (1-1.30 am SGT+1)

Click the button below to register for this event.